© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 21, 2020
According to recommendations, electronic media should actively engage in efforts to address the prevention and management of sickle cell disease.
The Full Field Peripheral Blood Smear application addresses shortcomings of current digital solutions.
October 20, 2020
A common theme among clinical staff focus groups was the pervasiveness of systemic and social barriers to addressing basic needs in children with sickle cell disease.
Stem cell transplantation can be a curative treatment for sickle cell disease, but there is some safety risks.
October 19, 2020
Multi-center, sickle cell studies may face a host of barriers and challenges in achieving target sample sizes.
October 16, 2020
Venetoclax in combination with azacitidine was shown to prolong survival and increase chance of remission.
October 09, 2020
New findings from the Congo highlight risks both mothers and their children face in delivery.
September 30, 2020
The orphan drug will be the first ever FDA-approved granular hydrocortisone formulation specifically developed for pediatric patients.
The complexities associated with the disease and lack of validated risk predictors makes such a model challenging to implement.
September 25, 2020
Mepolizumab will be used to treat both adult and pediatric patients with HES for at least 6 months without an identifiable non-hematologic secondary cause.